Cerebral Rhizomucor Infection Treated by Posaconazole Delayed-Release Tablets in an Allogeneic Stem Cell Transplant Recipient

Mucormycosis (zygomycosis) is an emerging fungal disease in allogeneic hematopoietic stem cell transplant (allo-HSCT) recipients. A 30-year-old woman diagnosed with acute myelomonocytic leukemia and needing allo-HSCT presented pulmonary and cerebral infection due to Rhizomucor pusillus. This fungal...

Full description

Bibliographic Details
Main Authors:	Diego O. Andrey, Laurent Kaiser, Stéphane Emonet, Veronique Erard, Yves Chalandon, Christian van Delden
Format:	Article
Language:	English
Published:	Elsevier 2017-02-01
Series:	International Journal of Infectious Diseases
Subjects:	Posaconazole delayed-release tablets Rhizomucor pusillus Zygomycosis Mucormycosis
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971216316575

id	doaj-84495dd6e8934b2d96b65a20fff3fc0d
record_format	Article
spelling	doaj-84495dd6e8934b2d96b65a20fff3fc0d2020-11-25T00:53:17ZengElsevierInternational Journal of Infectious Diseases1201-97121878-35112017-02-0155C242610.1016/j.ijid.2016.12.014Cerebral Rhizomucor Infection Treated by Posaconazole Delayed-Release Tablets in an Allogeneic Stem Cell Transplant RecipientDiego O. Andrey0Laurent Kaiser1Stéphane Emonet2Veronique Erard3Yves Chalandon4Christian van Delden5Service of Infectious Diseases, Department of Medical Specialties, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1211 Geneva 14, SwitzerlandService of Infectious Diseases, Department of Medical Specialties, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1211 Geneva 14, SwitzerlandService of Infectious Diseases, Department of Medical Specialties, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1211 Geneva 14, SwitzerlandService of Infectious Diseases, Hôpital Fribourgeois, Chemin des Pensionnats 2, 1708 Fribourg, SwitzerlandService of Hematology, Department of Medical Specialties, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1211 Geneva 14, SwitzerlandService of Infectious Diseases, Department of Medical Specialties, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1211 Geneva 14, SwitzerlandMucormycosis (zygomycosis) is an emerging fungal disease in allogeneic hematopoietic stem cell transplant (allo-HSCT) recipients. A 30-year-old woman diagnosed with acute myelomonocytic leukemia and needing allo-HSCT presented pulmonary and cerebral infection due to Rhizomucor pusillus. This fungal infection was treated with surgical treatment and posaconazole delayed-release tablets. This strategy allowed reaching high drug levels that could not be obtained with the posaconazole solution.http://www.sciencedirect.com/science/article/pii/S1201971216316575Posaconazole delayed-release tabletsRhizomucor pusillusZygomycosisMucormycosis
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Diego O. Andrey Laurent Kaiser Stéphane Emonet Veronique Erard Yves Chalandon Christian van Delden
spellingShingle	Diego O. Andrey Laurent Kaiser Stéphane Emonet Veronique Erard Yves Chalandon Christian van Delden Cerebral Rhizomucor Infection Treated by Posaconazole Delayed-Release Tablets in an Allogeneic Stem Cell Transplant Recipient International Journal of Infectious Diseases Posaconazole delayed-release tablets Rhizomucor pusillus Zygomycosis Mucormycosis
author_facet	Diego O. Andrey Laurent Kaiser Stéphane Emonet Veronique Erard Yves Chalandon Christian van Delden
author_sort	Diego O. Andrey
title	Cerebral Rhizomucor Infection Treated by Posaconazole Delayed-Release Tablets in an Allogeneic Stem Cell Transplant Recipient
title_short	Cerebral Rhizomucor Infection Treated by Posaconazole Delayed-Release Tablets in an Allogeneic Stem Cell Transplant Recipient
title_full	Cerebral Rhizomucor Infection Treated by Posaconazole Delayed-Release Tablets in an Allogeneic Stem Cell Transplant Recipient
title_fullStr	Cerebral Rhizomucor Infection Treated by Posaconazole Delayed-Release Tablets in an Allogeneic Stem Cell Transplant Recipient
title_full_unstemmed	Cerebral Rhizomucor Infection Treated by Posaconazole Delayed-Release Tablets in an Allogeneic Stem Cell Transplant Recipient
title_sort	cerebral rhizomucor infection treated by posaconazole delayed-release tablets in an allogeneic stem cell transplant recipient
publisher	Elsevier
series	International Journal of Infectious Diseases
issn	1201-9712 1878-3511
publishDate	2017-02-01
description	Mucormycosis (zygomycosis) is an emerging fungal disease in allogeneic hematopoietic stem cell transplant (allo-HSCT) recipients. A 30-year-old woman diagnosed with acute myelomonocytic leukemia and needing allo-HSCT presented pulmonary and cerebral infection due to Rhizomucor pusillus. This fungal infection was treated with surgical treatment and posaconazole delayed-release tablets. This strategy allowed reaching high drug levels that could not be obtained with the posaconazole solution.
topic	Posaconazole delayed-release tablets Rhizomucor pusillus Zygomycosis Mucormycosis
url	http://www.sciencedirect.com/science/article/pii/S1201971216316575
work_keys_str_mv	AT diegooandrey cerebralrhizomucorinfectiontreatedbyposaconazoledelayedreleasetabletsinanallogeneicstemcelltransplantrecipient AT laurentkaiser cerebralrhizomucorinfectiontreatedbyposaconazoledelayedreleasetabletsinanallogeneicstemcelltransplantrecipient AT stephaneemonet cerebralrhizomucorinfectiontreatedbyposaconazoledelayedreleasetabletsinanallogeneicstemcelltransplantrecipient AT veroniqueerard cerebralrhizomucorinfectiontreatedbyposaconazoledelayedreleasetabletsinanallogeneicstemcelltransplantrecipient AT yveschalandon cerebralrhizomucorinfectiontreatedbyposaconazoledelayedreleasetabletsinanallogeneicstemcelltransplantrecipient AT christianvandelden cerebralrhizomucorinfectiontreatedbyposaconazoledelayedreleasetabletsinanallogeneicstemcelltransplantrecipient
_version_	1725238324568784896

Cerebral Rhizomucor Infection Treated by Posaconazole Delayed-Release Tablets in an Allogeneic Stem Cell Transplant Recipient

Similar Items